The Persecution of Public Health: Why Targeting Anthony Fauci Over COVID-19 Origins Is a Dangerous Political Sideshow.
admin The Senate committee hearings held in early August 2026 regarding the origins of the Covid-19...
Health
The Washington Band Plays On: Why Targeting Fauci Distracts from the Real Lessons of Covid-19.
The recent Senate committee hearings regarding the origins of the Covid-19 pandemic have served as...
Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
The controversy centers on the implementation of the Drug Price Negotiation Program, a cornerstone of...
FDA approves Replimune melanoma drug previously rejected twice
The journey to this moment has been anything but linear. Replimune, a Massachusetts-based biotechnology firm,...
The Siege of Science: How a Day of Violence at the CDC Signaled the Fragility of American Public Health.
On the humid afternoon of August 8, 2025, the rhythmic, metallic sound of what I...
The Mirror of Compliance: Why AI in Medicine is the Ultimate Test of Physician Autonomy
Keep your head down; don’t ask too many questions; just finish your note and move...
The Great Biotech Migration: Why Massachusetts Is Losing Its Brightest Minds to Silicon Valley’s Creative Lure
By all rights, Felix Wong and his company should be in Massachusetts. Wong, 33, is...
Biotech’s Shifting Landscape: FDA Flexibility, Coastal Rivalries, and New Frontiers in Alzheimer’s Research
The biotechnology sector in 2026 finds itself at a pivotal crossroads, navigating a complex web...
A third clinic settles with DOJ over trans care
The legal mechanics of congressional contempt are rigorous and carry heavy penalties. Should the full...
FDA Approves Replimune’s Melanoma Drug Amid Controversy as Medicare Policy Shift Grants AbbVie a Multi-Billion Dollar Reprieve.
The landscape of oncology and pharmaceutical regulation underwent a seismic shift this week as the...
